褪黑素对严重慢性疼痛患者睡眠和疼痛有一致但短暂获益:DREAM-CP随机对照试验
这项随机双盲交叉试验纳入60例严重非癌性慢性疼痛患者,比较改良释放褪黑素(Circadin™)2 mg与安慰剂睡前服用6周。主要结局6周时睡眠紊乱未显著改善,但3周时睡眠紊乱、入睡潜伏期、整体睡眠质量和疼痛对睡眠的影响均有改善;两治疗期疼痛强度均改善且不良事件无差异。
要点
- 6周时褪黑素未显著改善主要结局睡眠紊乱。
- 3周时睡眠紊乱、入睡潜伏期、睡眠质量和疼痛对睡眠影响有改善。
- 两治疗期疼痛强度均改善,不良事件无差异。
核心结论
- Circadin™治疗6周时未改善严重慢性疼痛患者的睡眠紊乱,但短期在睡眠多个方面有一致改善。
- 鉴于其良好的安全性,可能对部分慢性疼痛患者有益。
研究设计与样本
- 随机双盲交叉试验,比较改良释放褪黑素(Circadin™)与安慰剂。
- 60例男性和女性严重慢性疼痛受试者随机接受2 mg Circadin™或安慰剂睡前服用6周,经过>4周洗脱后交叉到另一治疗。
主要发现
- 6周时睡眠紊乱未受褪黑素显著改变。
- 3周时褪黑素与安慰剂治疗期间差异:睡眠紊乱P=0.014、入睡潜伏期P=0.04、整体睡眠质量P=0.004、疼痛对睡眠的影响P=0.032。
- 两治疗期疼痛强度评分均改善(均P<0.001)。
- 两治疗期不良事件无差异。
关键数值与推荐
- 主要结局为治疗6周后自我报告的睡眠紊乱。
- 使用三种不同的验证睡眠评估工具测量睡眠紊乱、质量和潜伏期。
临床怎么用
- 可考虑将改良释放褪黑素2 mg用于部分严重慢性疼痛患者以短期改善睡眠多个方面。
- 需告知患者6周时主要睡眠结局未显著改善,获益可能短暂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sleep disturbance is a major issue for patients with chronic pain. Melatonin has been shown to improve symptoms of fibromyalgia, but its efficacy in other chronic non-malignant pain conditions is not fully known. Hence, we determined the effect of melatonin in patients with severe noncancer chronic pain. METHODS: This was a randomised double-blinded crossover trial of modified-release melatonin as Circadin™ compared with placebo. Sixty male and female subjects with chronic severe pain were randomised to receive either 2 mg of Circadin™ or placebo before sleep for 6 weeks, followed by a >4 week washout, then crossing over to the other treatment. Sleep disturbance, quality, and latency were measured using three different validated sleep assessment tools. The primary outcome measure was self-reported sleep disturbance after 6 weeks of treatment. Adverse events were also recorded. RESULTS: Sleep disturbance after 6 weeks was not significantly altered by melatonin treatment, but differences between melatonin and placebo treatment periods after 3 weeks were seen: sleep disturbance (P=0.014), latency (P=0.04), overall sleep quality (P=0.004), and effect of pain on sleep (P=0.032). Pain intensity scores improved during both treatment periods (both P<0.001). There were no differences in adverse events between treatment periods. CONCLUSIONS: Circadin™ treatment did not improve sleep disturbance in patients with severe chronic pain compared with placebo at 6 weeks, but there were consistent improvements in aspects of sleep in the shorter term. Given its favourable safety profile, it could be beneficial for some patients with chronic pain. CLINICAL TRIAL REGISTRATION: ISRCTN12861060.
引用
- Onyeakazi UM, Columb MO, Rosalind A, et al. Melatonin treatment has consistent but transient beneficial effects on sleep measures and pain in patients with severe chronic pain: the DREAM-CP randomised controlled trial. Br J Anaesth. 2024. PMID: 38355388. doi:10.1016/j.bja.2024.01.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。